关注
Mehmet Turgut
Mehmet Turgut
在 omu.edu.tr 的电子邮件经过验证
标题
引用次数
引用次数
年份
Azacitidine and venetoclax in previously untreated acute myeloid leukemia
CD DiNardo, BA Jonas, V Pullarkat, MJ Thirman, JS Garcia, AH Wei, ...
New England Journal of Medicine 383 (7), 617-629, 2020
18832020
Daratumumab plus bortezomib, melphalan, and prednisone for untreated myeloma
MV Mateos, MA Dimopoulos, M Cavo, K Suzuki, A Jakubowiak, S Knop, ...
New England Journal of Medicine 378 (6), 518-528, 2018
9832018
Brentuximab vedotin with chemotherapy for stage III or IV Hodgkin’s lymphoma
JM Connors, W Jurczak, DJ Straus, SM Ansell, WS Kim, A Gallamini, ...
New England Journal of Medicine 378 (4), 331-344, 2018
7532018
Randomized phase III trial of ibrutinib and rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in non–germinal center B-cell diffuse large B-cell lymphoma
A Younes, LH Sehn, P Johnson, PL Zinzani, X Hong, J Zhu, C Patti, ...
Journal of Clinical Oncology 37 (15), 1285-1295, 2019
5192019
Daratumumab-based treatment for immunoglobulin light-chain amyloidosis
E Kastritis, G Palladini, MC Minnema, AD Wechalekar, A Jaccard, HC Lee, ...
New England Journal of Medicine 385 (1), 46-58, 2021
3912021
Oral azacitidine maintenance therapy for acute myeloid leukemia in first remission
AH Wei, H Döhner, C Pocock, P Montesinos, B Afanasyev, H Dombret, ...
New England Journal of Medicine 383 (26), 2526-2537, 2020
3472020
Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial
P Moreau, MA Dimopoulos, J Mikhael, K Yong, M Capra, T Facon, ...
The Lancet 397 (10292), 2361-2371, 2021
2802021
Efficiency of atorvastatin in the protection of anthracycline-induced cardiomyopathy
Z Acar, A Kale, M Turgut, S Demircan, K Durna, S Demir, M Meriç, ...
Journal of the American College of Cardiology 58 (9), 988-989, 2011
2792011
Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study
R Diz-Kucukkaya, A Hacıhanefioglu, M Yenerel, M Turgut, H Keskin, ...
Blood, The Journal of the American Society of Hematology 98 (6), 1760-1764, 2001
2602001
Hemostatic efficacy of Ankaferd Blood Stopper® in a swine bleeding model
H Bilgili, A Kosar, M Kurt, IK Onal, H Goker, O Captug, A Shorbagi, ...
Medical Principles and Practice 18 (3), 165-169, 2009
1272009
Randomized phase III study of alisertib or investigator’s choice (selected single agent) in patients with relapsed or refractory peripheral T-cell lymphoma
OA O’Connor, M Özcan, ED Jacobsen, JM Roncero, J Trotman, J Demeter, ...
Journal of Clinical Oncology 37 (8), 613-623, 2019
1192019
The QUAZAR AML-001 maintenance trial: results of a phase III international, randomized, double-blind, placebo-controlled study of CC-486 (oral formulation of azacitidine) in …
AH Wei, H Döhner, C Pocock, P Montesinos, B Afanasyev, H Dombret, ...
Blood 134, LBA-3, 2019
1182019
In vitro anti-bacterial activities of Ankaferd medicinal plant extract
N Akkoc, M Akcelik, IC Haznedaroglu, H Goker, M Turgut, S Aksu, ...
Turkiye Klinikleri Tip Bilimleri Dergisi 29 (2), 410-415, 2009
832009
Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience
H Bekoz, M Ozbalak, N Karadurmus, S Paydas, A Turker, T Toptas, ...
Annals of Hematology 99, 2565-2576, 2020
812020
Multiple myeloma treatment in real-world clinical practice: results of a prospective, multinational, noninterventional study
M Mohty, E Terpos, MV Mateos, M Cavo, S Lejniece, M Beksac, ...
Clinical Lymphoma Myeloma and Leukemia 18 (10), e401-e419, 2018
772018
Predicting survival for multiple myeloma patients using baseline neutrophil/lymphocyte ratio
E Kelkitli, H Atay, F Çilingir, N Güler, Y Terzi, D Özatlı, M Turgut
Annals of hematology 93, 841-846, 2014
752014
Relation between hemostatic parameters and prognostic/predictive factors in breast cancer
E Yigit, G Gönüllü, İ Yücel, M Turgut, D Erdem, B Çakar
European journal of internal medicine 19 (8), 602-607, 2008
722008
Preoperative localization of parathyroid carcinoma using Tc-99m MIBI
MT Kitapci, G Tastekin, M Turgut, B Caner, A Kars, I Barista, C Bekdik
Clinical nuclear medicine 18 (3), 217-219, 1993
681993
Efficacy and safety of subcutaneous and intravenous rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in first-line diffuse large B-cell lymphoma: the …
P Lugtenburg, I Avivi, H Berenschot, O Ilhan, JP Marolleau, A Nagler, ...
Haematologica 102 (11), 1913, 2017
672017
Thrombocytopenia complicating the clinical course of leptospiral infection
M Turgut, M Sünbül, D Bayirli, A Bilge, H Leblebicioğlu, I Haznedaroğlu
Journal of International Medical Research 30 (5), 535-540, 2002
592002
系统目前无法执行此操作,请稍后再试。
文章 1–20